Clinical trial Recruiting at 1 site Observational Ages 18 and up

Factors that affect atrial tracking and atrial fibrillation in people receiving the Micra AV2 pacemaker

Official title: Determinates of Atrial Tracking and Prevalence of Atrial Fibrillation in the Micra AV2 (DANCE AFIB)

Run by Northwell Health · NCT07344961 · Data updated 2026-11-12

This will see how well the Micra AV2 device tracks atrial activity and how often short episodes of paroxysmal atrial fibrillation occur in adults who receive the device.

More Paroxysmal Atrial Fibrillation trials

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment50 (estimated)
SponsorNorthwell Health
Academic / other
Locations1 site (New Hyde Park, New York)
StatusRecruiting
StartedDecember 29, 2025
Main results expectedDecember 31, 2027
Study endsDecember 31, 2027
Registry record updatedFebruary 4, 2026
Trial IDNCT07344961 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are English-speaking adults aged 18–85 with a history of paroxysmal atrial fibrillation who are receiving a Micra AV2 pacemaker per standard clinical care and can attend follow-up.

Probably not a fit

Patients with persistent or chronic atrial fibrillation, those unable to complete follow-up, or those enrolled in conflicting device/drug studies are unlikely to benefit from the study's findings.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This prospective, descriptive observational study enrolls adults with a history of paroxysmal atrial fibrillation who are receiving a Micra AV2 pacemaker as part of standard care at Northwell Health. Investigators will perform periodic device interrogations and use a designated Medtronic research Holter monitor to capture Micra AV2 signals during sinus rhythm and during episodes of atrial fibrillation. The study will track the presence and effectiveness of atrial tracking, including atrial activity and A4 amplitude trends, over time but will not include formal safety endpoint assessments. Patients with persistent or chronic atrial fibrillation are excluded, and enrollment is limited to consenting English-speaking adults aged 18–85 who can complete follow-up.

Why it matters

Potential benefit: If successful, the results could help doctors identify which patients are most likely to get reliable atrial tracking from Micra AV2 and improve device programming and follow-up.

How similar studies have gone: Previous studies of Micra AV devices have shown that mechanical atrial sensing can work in many patients, but Micra AV2-specific data on atrial tracking in paroxysmal atrial fibrillation remains limited.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Participant or legally authorized representative (LAR) provides authorization and/or consent per institution and geographical requirements
* Participant has been implanted with the Micra AV2 device or is intended to receive or be treated with an eligible Micra AV2 device as per standard of care.
* Participants with a history of paroxysmal atrial fibrillation undergoing Micra AV2 implantation, as per standard of care.
* Age 18-85 years old with the ability to consent for the procedure
* Participant is consented within the enrollment window of the therapy received, as applicable
* English Speaking

Exclusion Criteria:

* Participant who is, or is expected to be, inaccessible for follow-up
* Participation is excluded by local law
* Participant is currently enrolled or plans to enroll in concurrent drug/device study that may confound the study results
* Participant with persistent/chronic atrial fibrillation
* Prisoner or cognitively impaired due to the study procedures involving independent wearing of the holter monitor for research purposes.

Where it's running

  • Long Island Jewish Medical Center
    New Hyde Park, New York, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.